Denali Therapeutics assumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Sean Laaman assumed coverage of Denali Therapeutics (DNLI) with an Overweight rating and a price target of $33, down ...
Mena FN9d
Investornewsbreaks Nanoviricides (NYSE American: NNVC) Highlights NV-387 As Potential Measles Treatment Amid Outbreak
Kennedy Jr. in a Fox News opinion piece. NV-387 has demonstrated efficacy against viruses that use heparan sulfate proteoglycans for cell attachment, including RSV, influenza, and coronaviruses, ...
Medscape9d
Rosacea: Newer Approaches to Diagnosis, Management
Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to ...
News-Medical.Net13d
Scientists uncover how a sugar shield in brain blood vessels protects against aging and disease
Researchers reveal that the loss of mucin-type O-glycosylation in the brain endothelial glycocalyx weakens the blood-brain ...
C&EN21d
Variant-Specific Interactions at the Plasma Membrane: Heparan Sulfate’s Impact on SARS-CoV-2 Binding Kinetics
Department of Clinical Microbiology, Umeå University, Umeå 901 87, Sweden Wallenberg Centre for Molecular Medicine (WCMM), Umeå University, Umeå 901 87, Sweden Umeå Centre for Microbial Research (UCMR ...
Business Insider23d
Ultragenyx’s BLA for UX111 accepted by FDA for priority review
The BLA submission for UX111 is supported by available data demonstrating treatment with UX111 resulted in rapid and sustained decreased levels of heparan sulfate in cerebrospinal fluid in ...
Scientific Research Publishing28d
Liu, J. and Thorp, S.C. (2001) Cell Surface Heparan Sulfate and Its Roles in Assisting Viral Infections. Medicinal Research Reviews, 22, 1-25.
ABSTRACT: The common cold is caused by a large range of respiratory viruses and is the most common disease of mankind. There is a great need for a prophylactic treatment for colds. Specific antiviral ...